Oral fludarabine: a viewpoint by Dieter Huhn.
Huhn
Dieter
D
Department of Medicine/Hematology and Oncology, Charitè Campus Virchow-Klinikum, Berlin, Germany.
D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001682:Biological Availability; D002986:Clinical Trials as Topic; D006801:Humans; D007275:Injections, Intravenous; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D014740:Vidarabine / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine